Human medicines European public assessment report (EPAR): Zynlonta, loncastuximab tesirine, Date of authorisation: 20/12/2022, Revision: 6, Status: Authorised

Scientific recommendations on classification of advanced therapy medicinal products

Minutes of the COMP meeting 7-8 October 2025

Step-by-step guide: How to evaluate a CT application - CTIS Training Programme - Module 06

European Medicines Agency’s data protection notice for PMS user acceptance stakeholder involvement

Human medicines European public assessment report (EPAR): Pedea, ibuprofen, Date of authorisation: 28/07/2004, Revision: 18, Status: Authorised

Accessibility

Human medicines European public assessment report (EPAR): Brukinsa, zanubrutinib, Date of authorisation: 22/11/2021, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR): Sirturo, bedaquiline, Date of authorisation: 05/03/2014, Revision: 23, Status: Authorised

Human medicines European public assessment report (EPAR): Lupkynis, voclosporin, Date of authorisation: 15/09/2022, Revision: 6, Status: Authorised